Investor FAQs

Show all

NewLink Genetics Corporation was incorporated in Delaware on June 4, 1999. 
NewLink Genetics’ corporate headquarters is in Ames, Iowa.
NewLink Genetics’ fiscal year-end is December 31.
NewLink Genetics’ independent registered public accounting firm is KMPG LLP.
NewLink Genetics’ common stock is traded under the ticker symbol NLNK on the NASDAQ Global Select Stock Market.
NewLink Genetics’ initial public offering was on November 11, 2011.
You can purchase shares of NewLink Genetics stock through a stockbroker. NewLink Genetics does not have a direct stock purchase program.
NewLink Genetics does not pay a cash or stock dividend on its common stock. NewLink Genetics anticipates that it will retain all available funds and any future earnings for use in the operation of its business and does not anticipate paying a dividend in the foreseeable future.
The CUSIP number for NewLink Genetics’ common stock is 651511107.
NewLink Genetics’ transfer agent is Computershare Shareowner Services LLC. Shareholders can contact them through the following channels: By phone:
Toll-free (888) 213-0965
Toll (201) 680-6578

By regular mail:
PO Box 30170
College Station, TX 77842

By overnight delivery:
211 Quality Circle
Suite 210
College Station, TX 77845 Shareholders can access their account online here.
A copy of our Annual Report or other periodic reports to the Securities and Exchange Commission is available without charge upon written request to: Corporate Secretary
NewLink Genetics Corporation
2503 South Loop Drive
Suite 5100
Ames, IA 50010
The names of NewLink Genetics’ Board of Directors can be found here.
The names of NewLink Genetics’ management team can be found here.
To contact NewLink Genetics Investor Relations, please send an email to
To contact NewLink Genetics Media Relations, please send an email to
You can find NewLink Genetics’ press releases here.
You can find information on NewLink Genetics’ R&D programs here.